Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The “Efficacy-Effectiveness Gap”: Historical Background and Current Conceptualization
Clémentine Nordon, Hélène Karcher, Rolf H. H. Groenwold, et al.
Value in Health (2015) Vol. 19, Iss. 1, pp. 75-81
Open Access | Times Cited: 143

Showing 1-25 of 143 citing articles:

Series: Pragmatic trials and real world evidence: Paper 1. Introduction
Mira G. P. Zuidgeest, Iris Goetz, Rolf H. H. Groenwold, et al.
Journal of Clinical Epidemiology (2017) Vol. 88, pp. 7-13
Open Access | Times Cited: 181
Opportunities and challenges in using real-world data for health care
Vivek A. Rudrapatna, Atul J. Butte
Journal of Clinical Investigation (2020) Vol. 130, Iss. 2, pp. 565-574
Open Access | Times Cited: 142
Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK
Tracey Weiss, Lingfeng Yang, Richard D. Carr, et al.
BMJ Open Diabetes Research & Care (2022) Vol. 10, Iss. 1, pp. e002517-e002517
Open Access | Times Cited: 86
Randomized controlled trials and real-world data: differences and similarities to untangle literature data
Sara Monti, V. Grosso, Monica Todoerti, et al.
Lara D. Veeken (2018) Vol. 57, Iss. Supplement_7, pp. vii54-vii58
Open Access | Times Cited: 126
Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria
Michael D. Tharp, Jonathan A. Bernstein, Abhishek Kavati, et al.
JAMA Dermatology (2018) Vol. 155, Iss. 1, pp. 29-29
Open Access | Times Cited: 122
Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics
Gloria D. Coronado, Amanda F. Petrik, William M. Vollmer, et al.
JAMA Internal Medicine (2018) Vol. 178, Iss. 9, pp. 1174-1174
Open Access | Times Cited: 115
Nonrandomized Real‐World Evidence to Support Regulatory Decision Making: Process for a Randomized Trial Replication Project
Jessica M. Franklin, Ajinkya Pawar, David Martin, et al.
Clinical Pharmacology & Therapeutics (2019) Vol. 107, Iss. 4, pp. 817-826
Closed Access | Times Cited: 100
Mailed Outreach and Patient Navigation for Colorectal Cancer Screening Among Rural Medicaid Enrollees
Gloria D. Coronado, Amanda F. Petrik, Michael C. Leo, et al.
JAMA Network Open (2025) Vol. 8, Iss. 3, pp. e250928-e250928
Open Access | Times Cited: 1
Global implementation of PrEP for HIV prevention: setting expectations for impact
Maria Pyra, Jessica E. Haberer, Nina Hasen, et al.
Journal of the International AIDS Society (2019) Vol. 22, Iss. 8
Open Access | Times Cited: 61
<p>Real-World Adherence and Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes Mellitus Patients in the United States</p>
Tracey Weiss, Richard D. Carr, Sampriti Pal, et al.
Patient Preference and Adherence (2020) Vol. Volume 14, pp. 2337-2345
Open Access | Times Cited: 59
A Scoping Review of 4 Decades of Outcomes in Nonsurgical Root Canal Treatment, Nonsurgical Retreatment, and Apexification Studies—Part 2: Outcome Measures
Amir Azarpazhooh, Adam Sgro, Elaine Cardoso, et al.
Journal of Endodontics (2021) Vol. 48, Iss. 1, pp. 29-39
Open Access | Times Cited: 42
Real‐world evidence for the long‐term effect of allergen immunotherapy: Current status on database‐derived European studies
Christian Vogelberg, Ludger Klimek, Bernd Brüggenjürgen, et al.
Allergy (2022) Vol. 77, Iss. 12, pp. 3584-3592
Open Access | Times Cited: 35
The efficacy and real-world effectiveness of a diet low in fermentable oligo-, di-, monosaccharides and polyols in irritable bowel syndrome: a systematic review and meta-analysis
Sandra Jent, Natalie Sara Bez, Joyce Haddad, et al.
Clinical Nutrition (2024) Vol. 43, Iss. 6, pp. 1551-1562
Open Access | Times Cited: 8
A primer on multiscale modelling of infectious disease systems
Winston Garira
Infectious Disease Modelling (2018) Vol. 3, pp. 176-191
Open Access | Times Cited: 53
Pharmacogenomics: A road ahead for precision medicine in psychiatry
Antonio F. Pardiñas, Michael J. Owen, James Walters
Neuron (2021) Vol. 109, Iss. 24, pp. 3914-3929
Open Access | Times Cited: 40
Real-world outcomes associated with new cancer medicines approved by the Food and Drug Administration and European Medicines Agency: A retrospective cohort study
Jemma M. Boyle, Gemma Hegarty, Christopher Frampton, et al.
European Journal of Cancer (2021) Vol. 155, pp. 136-144
Open Access | Times Cited: 34
Impact of Difelikefalin on the Health-Related Quality of Life of Haemodialysis Patients with Moderate-To-Severe Chronic Kidney Disease-Associated Pruritus: A Single-Arm Intervention Trial
James Fotheringham, Julian F. Guest, Joerg Latus, et al.
Patient (2024) Vol. 17, Iss. 2, pp. 203-213
Open Access | Times Cited: 5
The impact of hepatitis C virus outside the liver: Evidence from Asia
Zobair M. Younossi, Atsushi Tanaka, Yuichiro Eguchi, et al.
Liver International (2016) Vol. 37, Iss. 2, pp. 159-172
Open Access | Times Cited: 39
Patient preferences for symptom-driven or regular preventer treatment in mild to moderate asthma: findings from the PRACTICAL study, a randomised clinical trial
Christina Baggott, Helen K. Reddel, Jo Hardy, et al.
European Respiratory Journal (2020) Vol. 55, Iss. 4, pp. 1902073-1902073
Open Access | Times Cited: 38
Replication of Randomized, Controlled Trials Using Real-World Data: What Could Go Wrong?
David Thompson
Value in Health (2020) Vol. 24, Iss. 1, pp. 112-115
Open Access | Times Cited: 33
Magnitude of effect and sample size justification in trials supporting anti-cancer drug approval by the US Food and Drug Administration
Michelle B. Nadler, Brooke E. Wilson, Alexandra Desnoyers, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Real-world effectiveness and tolerability of switching to doravirine-based antiretroviral therapy in people with HIV: a nationwide, matched, prospective cohort study
Patrick G. A. Oomen, Ferdinand W N M Wit, Kees Brinkman, et al.
The Lancet HIV (2024) Vol. 11, Iss. 9, pp. e576-e585
Closed Access | Times Cited: 4
Embedding data provenance into the Learning Health System to facilitate reproducible research
Vasa Ćurčin
Learning Health Systems (2016) Vol. 1, Iss. 2
Open Access | Times Cited: 32
Can machine learning improve patient selection for cardiac resynchronization therapy?
Szu-Yeu Hu, Enrico Santus, Alexander W. Forsyth, et al.
PLoS ONE (2019) Vol. 14, Iss. 10, pp. e0222397-e0222397
Open Access | Times Cited: 30
Recalibrating Health Technology Assessment Methods for Cell and Gene Therapies
Aris Angelis, Huseyin Naci, Allan Hackshaw
PharmacoEconomics (2020) Vol. 38, Iss. 12, pp. 1297-1308
Closed Access | Times Cited: 28
Page 1 - Next Page

Scroll to top